PTPRC and intrahepatic cholangiocarcinoma: DAPI- cells from benign-enriched and ICC/IDC-enriched tissue were then recombined at a ratio of 30% CD45+, 25% EpCAM+, and 45% CD45-EpCAM- (Fig. 1a).